FDA Approves Nivolumab as Adjuvant Treatment for Melanoma
WEDNESDAY, Oct. 18, 2023 (HealthDay News) — The U.S. Food and Drug Administration has approved Opdivo (nivolumab) for the adjuvant treatment of completely resected stage IIB/C melanoma in patients ages 12 years and older.The approval was based on res…
Learn MoreLa inteligencia artificial tiene una tasa de éxito del 100% en la detección de melanomas
LUNES, 16 de octubre de 2023 (HealthDay News) — La capacidad de detectar el cáncer de piel utilizando software de inteligencia artificial (IA) ha mejorado rápidamente.Una nueva investigación presentada el miércoles en una conferencia médica en Berlín…
Learn MoreLatest AI Has 100% Success Rate in Spotting Melanomas
FRIDAY, Oct. 13, 2023 (HealthDay News) — The ability to detect skin cancer using artificial intelligence (AI) software has rapidly improved.New research presented Wednesday at a medical conference in Berlin shows that this AI technology now has a 100…
Learn MoreQuímicos PFAS comunes vinculados a cánceres en mujeres
MIÉRCOLES, 20 de septiembre de 2023 (HealthDay News) — Los perjudiciales “químicos eternos” están ampliamente distribuidos en el medio ambiente, y una nueva investigación sugiere que representan un riesgo particular para la salud de las mujeres.Un nue…
Learn MoreCommon PFAS Chemicals Linked to Cancers in Women
TUESDAY, Sept. 19, 2023 (HealthDay News) — Harmful “forever” chemicals are widespread in the environment, and new research hints they pose a particular health risk to women.A new study suggests women who are exposed to higher levels of per- and polyf…
Learn MoreFormer ‘Real Housewife’ Teddi Mellencamp Reveals Another Melanoma Diagnosis
THURSDAY, Sept. 14, 2023 (HealthDay News) — Reality TV star and wellness coach Teddi Mellencamp announced on Instagram Wednesday that she has been diagnosed with yet another melanoma.This is Mellencamp’s 12th or 13th melanoma, she said, noting in an …
Learn MoreIn Situ, Invasive Melanoma Diagnoses Decreased in 2020
THURSDAY, Sept. 7, 2023 (HealthDay News) — During 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 in JAMA Dermatology.Daniel Y. Kim, from Harvard Medical School, and…
Learn MoreIn Situ, Invasive Melanoma Diagnoses Decreased in 2020
THURSDAY, Sept. 7, 2023 (HealthDay News) — During 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 in JAMA Dermatology.Daniel Y. Kim, from Harvard Medical School, and…
Learn MoreNivolumab + Ipilimumab Tops Ipilimumab Alone in Metastatic Melanoma
WEDNESDAY, Aug. 23, 2023 (HealthDay News) — For patients with metastatic melanoma who receive frontline anti-programmed death protein 1 (PD-1) or therapy against programmed cell death 1 ligand 1 and whose tumors progressed with cytotoxic T-lymphocyte…
Learn MorePercentage of Women Mohs Fellows, Program Directors Has Increased
FRIDAY, Aug. 18, 2023 (HealthDay News) — Since 1996, there has been an increase in the percentage of women in Mohs micrographic surgery (MMS) fellowships and program directors (PDs), according to a research letter published online Aug. 9 in JAMA Derm…
Learn More